On July 13, 2011, Commissioner of Food and Drugs Dr. Margaret A. Hamburg announced a reorganization to create new “directorates” overseeing the core functions and responsibilities of the agency.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
FDA reorganization furthers pro-enforcement agenda, reflects global focus
To view this article you need a PDF viewer such as Adobe Reader.
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.